In Vitro Lung Model Market is expected to reach US$ 701.81 Mn by 2027


PRESS RELEASE BY The Insight Partners 27 Nov 2019

Share this press on


3D model segment is expected to grow at a fast pace over the forecast period

 

According to The Insight Partners market research titled ‘In Vitro Lung Model to 2027 – Global Analysis and Forecasts by Type, and Application.’ The global in vitro lung model market is anticipated to reach US$ 701.81 Mn in 2027 from US$ 185.80 Mn in 2018. The market is anticipated to grow with a CAGR of 16.2% from 2019-2027. The report provides the trends prevailing in the global In vitro lung model market and the factors driving the market along with those that act as hindrances.

 

The global in vitro lung model market, based on the type, is segmented into 2D, and 3D. In 2018, the 3D segment held the largest market share of the in vitro lung model market. This segment is also projected to dominate the market in 2027 as 3D in vitro lung models enhance the expression of gene regulation, soluble factors, and response to therapeutic agents.

 

The market for in vitro lung model is expected to grow, owing to factors such as significant growth in research funding, and increasing adoption of 3d model systems for in vitro studies. Moreover, growing research on lung diseases are likely to have a positive impact on the growth of the market in the coming years.

 

The leading companies operating in the in vitro lung model market include Epithelix Sàrl, MATTEK, LONZA, InSphero, Emulate, Inc., AlveoliX AG, Thermo Fisher Scientific Inc, PromoCell GmbH, Merck KGaA, and Horizon Discovery Group plc. among others. The market has observed various organic as well as inorganic developments during recent years in the in vitro lung model market. For instance, in October 2017, InSphero AG and Charles River Laboratories International, Inc. announced a partnership through which Charles River will license its collection of patient-derived xenograft (PDX) tumors to InSphero.

 

Global In Vitro Lung Model Market, By Regions, 2018 (%)


In Vitro Lung Model Market to Grow at a CAGR of 16.2% to reach US$ 701.81 Mn Million from 2019 to 2027

Download Free Sample

In Vitro Lung Model Market to 2027- Global Analysis and Forecasts by Type (2D, 3D); Application (Drug Screening, Toxicology, 3D Model Development, Physiologic Research, Stem Cell Research, Regenerative Medicine) and Geography


 

The report segments Global In Vitro Lung Model Market as follows:

 

Global In Vitro Lung Model Market – By Type

  • 2D
  • 3D

Global In vitro lung model Market – By Application

  • Drug Screening
  • Toxicology
  • 3D Model Development
  • Physiologic Research
  • Stem Cell Research
  • Regenerative Medicine

Global In Vitro Lung Model Market – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina

 

Contact Us

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

Download Free PDF Brochure